Ecuador vs Oman: New cases tested for RR-/MDR-TB
Ecuador
100.0%
in 2024
Oman
100.0%
in 2024
Ecuador rank
1st
Oman rank
1st
New cases tested for RR-/MDR-TB over time
- Ecuador
- Oman
How they compare
Ecuador currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 4 times across 16 shared years of data; in 2005 it was Oman ahead.
Ecuador ranks 1st and Oman ranks 1st of 192 countries.
Across the 3 decades both report, Ecuador averaged higher in 1 and Oman in 2.
Head to head by decade
| Decade | Ecuador | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 66.7% | 63.2% | Oman |
| 2010s | 21.7% | 94.9% | 73.2% | Oman |
| 2020s | 95.8% | 91.2% | 4.6% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ecuador or Oman?
- Ecuador, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ecuador and Oman?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Oman?
- 16 years are reported by both, from 2005 to 2024.
- How do Ecuador and Oman rank globally for new cases tested for rr-/mdr-tb?
- Ecuador ranks 1st and Oman ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.